Advertisement

Topics

Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Arthritis, Rheumatoid, Date of authorisation: 23/06/2017, Revision: 2, Status: Authorised

11:51 EDT 16 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Arthritis, Rheumatoid, Date of authorisation: 23/06/2017, Revision: 2, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Arthritis, Rheumatoid, Date of authorisation: 23/06/2017, Revision: 2, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Arthritis, Rheumatoid, Date of authorisation: 23/06/2017, Revision: 2, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...